Creek Drive Management Group LLC Makes New Investment in Dominari Holdings Inc. $DOMH

Creek Drive Management Group LLC bought a new stake in Dominari Holdings Inc. (NASDAQ:DOMH) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 376,000 shares of the company’s stock, valued at approximately $1,861,000. Dominari comprises approximately 1.3% of Creek Drive Management Group LLC’s investment portfolio, making the stock its 25th biggest position.

Several other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Dominari by 8.0% during the third quarter. Vanguard Group Inc. now owns 345,896 shares of the company’s stock worth $2,452,000 after purchasing an additional 25,694 shares during the last quarter. Connective Capital Management LLC increased its stake in shares of Dominari by 26.2% in the third quarter. Connective Capital Management LLC now owns 335,273 shares of the company’s stock valued at $2,377,000 after buying an additional 69,545 shares during the period. Two Sigma Investments LP bought a new position in Dominari in the 3rd quarter valued at approximately $771,000. Geode Capital Management LLC raised its holdings in Dominari by 8.9% in the 4th quarter. Geode Capital Management LLC now owns 88,293 shares of the company’s stock valued at $437,000 after buying an additional 7,244 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in Dominari during the 4th quarter worth approximately $412,000. 42.48% of the stock is currently owned by institutional investors.

Dominari Stock Performance

Dominari stock opened at $3.37 on Friday. Dominari Holdings Inc. has a 52-week low of $2.68 and a 52-week high of $8.40. The firm has a 50 day moving average price of $3.20 and a two-hundred day moving average price of $3.56. The firm has a market cap of $76.20 million, a price-to-earnings ratio of -0.84 and a beta of 0.80.

Dominari (NASDAQ:DOMH) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($2.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($1.94). Dominari had a negative return on equity of 206.20% and a negative net margin of 31.37%.The firm had revenue of $35.81 million during the quarter, compared to analyst estimates of $35.80 million.

Dominari Dividend Announcement

The company also recently announced a special dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a $0.31 dividend. The ex-dividend date was Friday, May 15th.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Dominari from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.